The company has sued the federal government over accusations that the FDA passed trade secrets about its schizophrenia drug Fanapt and sleep-disorder medication Hetlioz to generic competitors.
A massive recall of Philips breathing devices in 2021 due to a risk of potential injury has left physicians scrambling to find alternatives for the growing number of people who use them.
FDA said reports of faulty Philips ventilators and sleep apnea machines had risen in the past quarter, underlining problems facing the Dutch company, which has just announced plans to replace its CEO.